Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.

Previous studies of Mycobacterium fortuitum identified isolates that did not fit its two recognized biovariants. Eighty-five clinical isolates of this group, the "third biovariant complex", were evaluated. They represented 16% of 410 isolates of M. fortuitum submitted to a Texas laboratory and 22% of 45 isolates in Queensland, Australia. Most infections (76%) involved skin, soft tissue, or bone and occurred after metal puncture wounds or open fractures. Isolates differed from biovar fortuitum in resistance to pipemidic acid and use of mannitol and inositol as carbon sources. Two subgroups were present, and examples were deposited in the American Type Culture Collection. Isolates were resistant to doxycycline and one-third were resistant to cefoxitin. All were susceptible to amikacin, ciprofloxacin, sulfamethoxazole, and imipenem. Surgical debridement combined with drug therapy based on in vitro susceptibilities resulted in cures of cutaneous disease or osteomyelitis. DNA homology studies are needed to determine the taxonomic status of these organisms.

[1]  R. Wallace,,et al.  Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy , 1990, Antimicrobial Agents and Chemotherapy.

[2]  R. Wallace,,et al.  Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. , 1989, The Journal of infectious diseases.

[3]  J. Musser,et al.  Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. , 1989, The Journal of infectious diseases.

[4]  R. Wallace,,et al.  Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae , 1987, Journal of clinical microbiology.

[5]  R. Wallace,,et al.  Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility. , 1986, The American review of respiratory disease.

[6]  C Thornsberry,et al.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae , 1985, Antimicrobial Agents and Chemotherapy.

[7]  R. Wallace,,et al.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. , 1985, The Journal of infectious diseases.

[8]  K. E. Price,et al.  Presence of aminoglycoside acetyltransferase and plasmids in Mycobacterium fortuitum. Lack of correlation with intrinsic aminoglycoside resistance. , 1984, The American review of respiratory disease.

[9]  R. Good,et al.  Spectrum of disease due to rapidly growing mycobacteria. , 1983, Reviews of infectious diseases.

[10]  M. Daffé,et al.  Identification of Mycobacterium fortuitum and Mycobacterium chelonei , 1983, Journal of clinical microbiology.

[11]  I. Baess.  Deoxyribonucleic acid relatedness among species of rapidly growing mycobacteria. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.

[12]  R. Wallace,,et al.  Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei , 1982, Journal of clinical microbiology.

[13]  C. Thornsberry,et al.  Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution , 1982, Antimicrobial Agents and Chemotherapy.

[14]  R. Good,et al.  Identification of clinically significant Mycobacterium fortuitum complex isolates , 1981, Journal of clinical microbiology.

[15]  M. Tsukamura.  Numerical Analysis of Rapidly Growing, Nonphotochromogenic Mycobacteria, Including Mycobacterium agri (Tsukamura 1972) Tsukamura sp. nov., nom. rev. , 1981 .

[16]  I. Baess.  Deoxyribonucleic Acid Relatedness Among Species of Slowly‐Growing Mycobacteria , 1979, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology.

[17]  R. Gordon,et al.  Cooperative numerical analysis of rapidly growing mycobacteria. The second report. , 1977 .

[18]  J. Grange,et al.  Reevaluation of Mycobacterium fortuitum (Synonym: Mycobacterium ranae) , 1974 .

[19]  J. Grange,et al.  A study of Mycobacterium fortuitum (ranae). , 1974, Journal of medical microbiology.

[20]  G. Kubica,et al.  A co-operative numerical analysis of rapidly growing mycobacteria. , 1972, Journal of general microbiology.